Search Results

Terry Kenakin takes you on a captivating tour through the history of pharmacology : a journey that spans Whether you're stepping into pharmacology for the first time or rekindling your interest, this lesson Terry’s Corner, your essential launchpad into the world of therapeutic science Unlock "The History of Pharmacology

In the newest foundational lesson from Terry Kenakin’s Pharmacology Vault , we unlock the visual language of pharmacology: dose-response curves . 👉 Discover why dose-response curves are the backbone of all pharmacology.

Welcome to Terry’s Corner , where foundational pharmacology is demystified by someone who’s spent over In his newest lesson, “The Uniqueness of Pharmacology in Drug Discovery,” Terry Kenakin explains why pharmacology isn’t a clean-cut science—it’s a dynamic dialogue between molecule and system. You’ll uncover: Why pharmacology is the glue between chemistry and biology How to interpret drug behavior the story it’s telling. 👉 Start your journey with Terry’s foundational series Unlock "Unique Role of Pharmacology

March 2022 Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief Commercial Officer "SAN DIEGO – March 1, 2022 – Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization

Did you know that each month we collect the most recent #GPCR publications and the newest Biotech/Pharma

December 2021 Crinetics Pharmaceuticals announced the formation of an independently operated new company and Crinetics to Collaborate on Multiple Additional targets SAN DIEGO, October 18, 2021 — Crinetics Pharmaceuticals (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization

We’ve made some updates to the Principles of Pharmacology I & II courses, and we can’t wait for you Here’s the refreshed schedule: Principles of Pharmacology I October 3, 10, 17, 24 Principles of Pharmacology Don’t miss out on insightful resources like '   Applying Pharmacology to Drug Discovery ' and ' Advanced Data Analysis for GPCR Pharmacology .' Don’t miss your chance to dive into the Principles of Pharmacology I & II BUNDLE .

Richard is the architect behind nearly all of Exscientia's partnerships and collaborations across pharma

As Chief Matchmaker, I recently had the pleasure of speaking with Beth Fleck, Director of In Vitro Pharmacology at Crinetics Pharmaceuticals.  Beth is also the hiring manager for their open Principal Scientist, In Vitro Pharmacology role posted Top candidates will have a solid foundation in GPCR pharmacology as well as some experience in drug discovery

This Week’s Highlights: G protein-coupled receptor (GPCR) pharmacogenomics Miles D Thompson , David Jonasson, CFO & CBO at Absci Octant: A Next Generation Approach to Genetic Disease Antiverse, Nxera Pharma to GPCR Drug Discovery March 12 - 14, 2025 | NextGen Biomed 2025 March 25 - 28, 2025 | 10th German Pharm-Tox GPCR Jobs NEW GPCR Molecular Pharmacologist Scientist - Biology Scientist I Cell Biology - Tectonic Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser Group

treatment selection in patients with advanced haematological cancers, international partnerships with pharma

This week's highlights: Driving Pharma Innovation in Oncology: Domain Therapeutics' Success Proven by The Neuromedin U system: pharmacological implications for the treatment of obesity and binge eating behavior 2023 Financial Results Scientists Discover a New Way To Develop Drugs Without Side Effects Driving Pharma

I We are diving into the second class of our Principles of Pharmacology I course with enthusiasm and Seize this opportunity to enhance your expertise and proficiency in pharmacology! Modules: October 31st : The Eyes to See- The Importance of Pharmacologic Assays. s dive into the   Classified GPCR News from September 30th to October 6th, 2024 Industry News Nxera Pharma experienced commercial R&D executive Makoto Sugita as Chief Medical Officer and President of Nxera Pharma

and Daniel Isom  for their research on Advances in yeast synthetic biology for human GPCR biology and pharmacology Materials Access to the private group Certificate of participation Learn the essentials: Measuring the pharmacologic genetic disease Advances in yeast synthetic biology for human G protein-coupled receptor biology and pharmacology DMS: Linking Protein Structure To Function AbbVie Completes Acquisition of Cerevel Therapeutics Nxera Pharma 7, 2024 | 16th Annual PEGS Europe   July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology

discovery teams from advancing compounds based on artifacts of expression systems rather than intrinsic pharmacology If the assay threshold is too high, real pharmacology becomes invisible. Whole-Cell Responses: A Historical Complication Historically, pharmacology relied on whole-cell or tissue Why Terry’s Corner Terry’s Pharmacology Corner delivers weekly lectures from Dr. It is designed for: Pharmacologists sharpening foundational tools Discovery teams solving assay bottlenecks

GPCRs are one of the most important families of therapeutic targets in the pharmaceutical industry The final pharmacophore is derived from a set of at least 3-5 different chemical scaffolds. The pharmacophore is then functionalized in the best position for introducing a linker. This provides valuable information regarding the potential fitting of our three pharmacophores through Biomedicine & Pharmacotherapy 2022 , 153 , 113408. https://doi.org/10.1016/j.biopha.2022.113408 . (5

community by expanding access to validated, industry-standard GPCR assay platforms that enable rigorous pharmacological internalization, calcium flux, and ligand binding, generating multidimensional datasets trusted by leading pharmaceutical accelerate GPCR-targeted drug discovery by connecting scientists with proven assay platforms, deep pharmacological expertise and coverage of over 90% of the human GPCRome, Eurofins DiscoverX assays are trusted by leading pharmaceutical companies worldwide to generate high-quality, decision-enabling pharmacological data.

It is operational pharmacology designed to prevent avoidable setbacks. Premium Members also receive a 50%+ discount on Terry’s Corner , unlocking advanced pharmacology depth

Career opportunities:  In vitro Pharmacology Research Assistant—Geneva. built in public. 👉 Email us to chat, collaborate and tell us what you need ➤ Terry’s Corner—Basic Pharmacokinetics Pharmacokinetics isn’t a late-stage checkbox—it’s a decision framework that shapes every viable drug Why this matters now: PK defines translatability  — activity without exposure is not pharmacology. GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

A diverse pharmacopoeia of cannabinoid ligands is available, which has led to considerable advancements development and progress in optimising physicochemical properties, understanding advanced molecular pharmacology

October 2022 Pharmacological targeting of cGAS/STING-YAP axis suppresses pathological angiogenesis and Pharmacological targeting of cGAS/STING-YAP signaling by both a small-molecule STING agonist, SR-717, Further, pharmacological targeting of cGAS/STING-YAP axis exhibits the potential to alleviate liver and

A diverse pharmacopeia of cannabinoid ligands is available, which has led to considerable advancements development and progress in optimizing physicochemical properties, understanding advanced molecular pharmacology

The aim of this study was to test this hypothesis pharmacologically by using potent and selective Gq/

August 2022 A NanoBRET-Based H 3 R Conformational Biosensor to Study Real-Time H 3 Receptor Pharmacology monitor the activation state of G protein-coupled receptors are a useful addition to the molecular pharmacology

August 2022 Dopamine D 1 receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, We now summarize important pharmacological, molecular, and cellular studies relevant to D1-mediated β-arrestin-related

ACCESS data for Structure Therapeutics’ oral GLP-1 agonist aleniglipron, Principal Scientist—In Vitro Pharmacology More new courses arrive weekly in 2026, expanding coverage across GPCR pharmacology fundamentals. demand for clearer interpretation, stronger experimental design, and better decision-making across GPCR pharmacology

If your work touches GPCR pharmacology, these insights aren’t optional—they’re essential. Career opportunities:  Senior/Principal Scientist—GPCR Pharmacology; Principal Scientist—In Vitro Pharmacology Terry’s Corner: GPCR Pharmacology Insights That Prevent Real Drug Discovery Failures Discovery collapses Researchers, pharmacologists, biotech teams, and decision-makers who rely on accurate, efficient, interpretation-first

detailed structure‐activity relationship that identifies small changes to the ligands that invert their pharmacological

September 2022 Dynamics of tumor-associated macrophages in a quantitative systems pharmacology model of immunotherapy in triple-negative breast cancer "Quantitative systems pharmacology (QSP) modeling is an emerging mechanistic computational approach that couples drug pharmacokinetics/pharmacodynamics and

What started as hand-built assays on ice has become integrated platforms for drug discovery, systems pharmacology